We are delighted to share that we have been shortlisted as a finalist in the Excellence in Innovation category at the Medilink Midlands Business Awards 2025.
Addressing CMC considerations early in the drug development process is vital in the successful creation of a pharmaceutical product.
Addressing CMC considerations early in the drug development process is vital in the successful creation of a pharmaceutical product.
CMC refers to the set of activities that ensure a drug product is consistently produced, controlled, and meets the required quality standards.
Without a strong CMC strategy, even a promising drug candidate can fail to reach the market. Discover the foundation for product development.
The CMC section of a regulatory submission is essential as it ensures that the final product can be manufactured consistently and reliably.
Upperton is proud to announce its selection as a winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.
A well-implemented Quality Management System (QMS) is the backbone of a successful technology transfer. Learn more in our guide.
Tech transfer is the process of moving a product’s manufacturing process, related knowledge and documentation, from one facility to another.
Discover more about our team. In this Spotlight, meet our QC Manager, Danielle Young, on her journey with Upperton.
Driven by experts, led by science
Integrated CDMO services
By Development Stage
Development Platforms
Route of delivery
About Us
Our Approach
Events
Resources
Policies
Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA, UK. Phone: +44 (0) 115 855 7050 Email: contact@upperton.com
Copyright © 2025 Upperton Limited. Registration number: 03833301. Registered office address: Albert Einstein Centre, Nottingham Science Park, Nottingham, NG7 2TN. Registered in England. All rights reserved.
Speak with our team of experts and set up a discovery call to discuss your project in more detail.